Scoop: Bob Nelsen is building a Really Big Neuroscience Company

Jason Mast

Editor

Over the last year, ARCH managing director Bob Nelsen has been quietly raising hundreds of millions of dollars to launch a massive neuroscience-focused biotech. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Scoop: Bob Nelsen is building a Really Big Neuroscience Company

Jason Mast

Editor

Sign up to read this article for free.

Uro-Oncology Business Manager

ImmunityBio, Inc.

Remote

Updated: White House threatens ‘most favored nation’ plan to lower US drug prices, but many questions remain

Pharma investors brush off Trump’s ‘most favored nation’ plan as stocks rise

Watch Post-Hoc Live: Trump's 'most favored nation' plan to cut drug prices

GSK to pay $1.2B upfront to snag Boston Pharma’s mid-stage MASH hope

Bristol Myers CEO says America’s biopharma pole position is not guaranteed

It's been three months without a biotech IPO

Scoop: Bob Nelsen is build­ing a Re­al­ly Big Neu­ro­science Com­pa­ny

Editor

Sign up to read this article for free.

more like this

ImmunityBio, Inc.

Remote

Scoop: Bob Nelsen is building a Really Big Neuroscience Company